TriAgenics
TriAgenics
Company Overview
TriAgenics is an oral health company that has developed a treatment designed to prevent wisdom teeth from ever forming. TriAgenics’ revolutionary Zero3™ TBA (3rd molar tooth bud ablation) is a one-minute, preventive-care treatment for children ages 6-12. Zero3 treatment is expected to eliminate ALL painful complications normally associated with having wisdom teeth surgically removed. TriAgenics’ Zero3 technology is designed to gently warm the center of the patients’ developing wisdom tooth buds. This high-precision, minimally invasive treatment prevents tooth buds from ever developing into wisdom teeth. It is expected that there will be no recovery period following treatment, with no risk of dry socket and minimal risk of post-op infections. In sharp contrast, it takes an average of 3 days to recover from having wisdom teeth surgically removed. In multiple live animal trials to date, the Zero3 TBA procedure has been 100% effective in preventing teeth from ever forming with no recovery problems. This patented treatment and technology offers parents and dental professionals a safe, effective and simple way to prevent the broad array of diseases, extensive damage and lifelong hazards caused by wisdom teeth.
Products & Services
Zero3 TBA System
TriAgenics’ business model is similar to Align Technology’s Invisalign clear braces marketing strategy. Dentists will pay TriAgenics $350 per tooth bud for patient-specific Zero3 TBA treatment kits. Treatment takes just seconds. TriAgenics’ custom 3TBA guide snaps onto patients’ teeth (like a mouthguard) to position the 3TBA handpiece tip quickly and accurately for precise treatment. Using less than 5 watts, the handpiece delivers a small thermal dose that gently warms each wisdom tooth bud from its center outwards. This low-energy treatment irreversibly blocks wisdom teeth from forming without causing damage outside the prescribed 4-8 mm treatment zone. The small puncture made by the handpiece requires no recovery time following treatment and eliminates all complications normally associated with wisdom tooth extraction. Product development is complete. Zero3 TBA is protected by 24 U.S. and international patents. TriAgenics expects to obtain FDA approval in 2024.
Media Gallery
video placeholder image
TriAgenics Image 1
Company Stats
Key metrics about TriAgenics
Fuel Level
Engagement metrics for TriAgenics
Fuel represents engagement and interest in this company from the Crowdigy community.
Are you the owner of TriAgenics?
Claim your company profile to respond to reviews, update your information, and connect with investors.
Claim This Company